Sun Pharma

Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…

Dilip Shanghvi will continue as the Executive Chairman of the Board, while Richard Ascroft joins Sun Pharma as CEO – North…

SCD-044 trials for psoriasis and atopic dermatitis show no major safety concerns

If the QR code system is not all that it was promised to be, what are the next steps to safeguard our medicines?

Dr Avi Chaudhuri, expert on anti-counterfeiting has further analysed the recent counterfeiting case of Sun Pharma’s Levipil 500.…

Phase 2b study and supporting research highlight MM-II’s potential in symptomatic knee osteoarthritis; new findings presented at…

Dr Avi Chaudhuri, a global expert on anti-counterfeiting has written extensively on the deficits of the recently mandated QR…

Shaik Barak Tulla to drive commercial planning and business acceleration at Sun Pharma with over 25 years of pharma industry…

GlobalData analyst highlights Leqselvi’s high-dose advantage and renewed market entry as key drivers for swift adoption, despite…

Under license from Korea’s Daewoong Pharmaceutical, Sun Pharma introduces FEXUCLUE, a potassium-competitive acid blocker for…